Image not available in RecallScope.
Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles (NDC 0378-1813-10)
Official notice
18 Dec 2024
An official FDA notice concerns Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-count bottles (NDC 0378-1813-10). Superpotent Drug and Subpotent Drug: potency failures obtained Published 2024-12-18.
What to do now
Do not use the affected product. Contact your healthcare provider or pharmacist and follow the instructions on the official FDA notice.
Units affected
92,512
Recall number
D-0118-2025
Official notice
2024-12-18
The hazard
The hazard
Superpotent Drug and Subpotent Drug: potency failures obtained
How to check if you’re affected
How to check if you’re affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Event Ids
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Units affected
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand: Viatris. Contact: Viatris Inc.
Source & status
Source & status
Recall details
Recall details
Recall number
Event ID
Units affected
Status
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week’s recalls before you need them.
One email every Monday with official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.